Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 2144
2021 1447
2022 581
2023 245
2024 115
2025 87
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,070 results

Results by year

Filters applied: . Clear all
Page 1
Synthesis and multidimensional investigation of a tetra-substituted imidazole derivative: Spectroscopy, DFT/NLO properties, toxicity analysis, molecular docking, and dynamics simulation.
Babu RM, Lakshmaiya N. Babu RM, et al. Drug Chem Toxicol. 2026 Feb 11:1-27. doi: 10.1080/01480545.2026.2620408. Online ahead of print. Drug Chem Toxicol. 2026. PMID: 41674190
Molecular docking and molecular dynamics (MD) simulations were performed to evaluate the interaction of the synthesized imidazole derivative BDIM with key SARS-CoV-2 target proteins 6WCF, 6Y84, and 6LU7, compared with hydroxychloroquine and native liga …
Molecular docking and molecular dynamics (MD) simulations were performed to evaluate the interaction of the synthesized imidazole derivative …
Sustainable Synthesis and Medicinal Profiling of Azo-Anchored Imidazo[4,5-b]Indole Scaffolds: DFT Studies, Electrochemical Sensing, and Pharmacokinetic Evaluation.
Geedkar D, Kumar A, Sharma R, Sharma P. Geedkar D, et al. Arch Pharm (Weinheim). 2026 Feb;359(2):e70195. doi: 10.1002/ardp.70195. Arch Pharm (Weinheim). 2026. PMID: 41639604
Molecular docking predicted that compound 5(f) may interact favorably with the SARS-CoV-2 spike protein, showing better docking scores than Chloroquine and Hydroxychloroquine. ...
Molecular docking predicted that compound 5(f) may interact favorably with the SARS-CoV-2 spike protein, showing better …
Artemether-lumefantrine versus pyronaridine-artesunate for the treatment of malaria in patients with mild to moderate COVID-19 in Kenya and Burkina Faso: a randomised open-label trial (MALCOV).
Tangara B, Barsosio HC, Marlais T, Kabore JMT, Tiono AB, Otieno K, Wanjiku M, Achieng M, Onyango ED, Ondieki ED, Aura H, Odawo T, Allen DJ, Hannan L, Tetteh KK, Soulama I, Ouedraogo A, Serme SS, Soulama BI, Barry A, Badoum ES, Matthewman J, Brazal-Monzó H, Canizales J, Drabko A, Wu W, Kariuki S, Lesosky M, Sirima SB, Drakeley C, Ter Kuile FO. Tangara B, et al. EClinicalMedicine. 2026 Jan 3;91:103735. doi: 10.1016/j.eclinm.2025.103735. eCollection 2026 Jan. EClinicalMedicine. 2026. PMID: 41552003 Free PMC article.
BACKGROUND: It is unknown whether the choice of malaria treatment for uncomplicated malaria affects coronavirus disease 2019 (COVID-19) severity, severe acute respiratory syndrome coronavirus 2 (SARS-CoV
BACKGROUND: It is unknown whether the choice of malaria treatment for uncomplicated malaria affects coronavirus disease 2019 (COVI
Association Between Pre-hospital Medication Use and Outcomes in Patients Hospitalized for COVID-19 Pneumonia: A Multicenter Observational Study in the Netherlands.
Li L, Goris-de Geus J, de Leeuw I, Kanits F, Zegers J, van Zadelhoff A, Buenen N, Rettig TCD, Hoir MPL, Duijzer G, Geleijnse JM, Endeman H. Li L, et al. Cureus. 2025 Dec 15;17(12):e99243. doi: 10.7759/cureus.99243. eCollection 2025 Dec. Cureus. 2025. PMID: 41541948 Free PMC article.
Background Home medication use may influence the clinical trajectory of COVID-19, yet its association with adverse outcomes such as intensive care unit (ICU) admission and in-hospital death remains unclear. ...These findings underscore the importance of further rese …
Background Home medication use may influence the clinical trajectory of COVID-19, yet its association with adverse outcomes su …
Evaluation of the cardiopulmonary effects of repurposed COVID-19 therapeutics in healthy rats.
Ozhan O, Yildiz A, Bakar B, Ulu A, Kucukakcali Z, Karaca E, Vardi N, Ates B, Parlakpinar H. Ozhan O, et al. Sci Rep. 2026 Jan 14;16(1):1770. doi: 10.1038/s41598-025-31048-4. Sci Rep. 2026. PMID: 41535311 Free PMC article.
Hydroxychloroquine (HCLQ), favipiravir (FAVI), molnupiravir (MOL) and dexamethasone (DEX) are recently used drugs, some of which are currently used in the treatment of Coronavirus Disease (COVID-19). We aimed to investigate the cardiovascular and pulmo
Hydroxychloroquine (HCLQ), favipiravir (FAVI), molnupiravir (MOL) and dexamethasone (DEX) are recently used drugs, some of which are
Exploring molecular interactions of drugs in different biologically active solvents: A comprehensive review for safe and efficient drug delivery systems.
Kumar P, Ahir P, Sharma S, Thakur V, Verma P, Kumar I, Bharti V, Kumar S. Kumar P, et al. Int J Biol Macromol. 2026 Jan;340(Pt 2):150197. doi: 10.1016/j.ijbiomac.2026.150197. Epub 2026 Jan 10. Int J Biol Macromol. 2026. PMID: 41525859
There have been reports of improved solubility and stability of drugs like metformin hydrochloride and hydralazine hydrochloride in aqueous solutions of carbohydrates and amino acids, which has an immediate effect on their bioavailability and treatment efficacy. Moreover, the …
There have been reports of improved solubility and stability of drugs like metformin hydrochloride and hydralazine hydrochloride in aqueous …
Miracle cures, wonder drugs, and unproven treatments for COVID-19: A global database.
Lasco G, Loreche AM, Aguilar MAD, Yu VG. Lasco G, et al. Soc Sci Med. 2026 Feb;391:118901. doi: 10.1016/j.socscimed.2025.118901. Epub 2025 Dec 25. Soc Sci Med. 2026. PMID: 41468774
BACKGROUND: Throughout the COVID-19 pandemic, various substances were promoted and used as preventive measures, cures, and treatments for COVID-19, from repurposed drugs to traditional medicines and herbal remedies. ...Our novel scientific contribution …
BACKGROUND: Throughout the COVID-19 pandemic, various substances were promoted and used as preventive measures, cures, and tre …
Health disinformation: a call to action for the hemostasis and thrombosis community.
Smadja DM. Smadja DM. Res Pract Thromb Haemost. 2025 Nov 19;9(8):103272. doi: 10.1016/j.rpth.2025.103272. eCollection 2025 Nov. Res Pract Thromb Haemost. 2025. PMID: 41458976 Free PMC article.
The COVID-19 pandemic has exposed a parallel crisis: an infodemic of unprecedented scale and impact. ...Within this hostile informational ecosystem, fringe theories proliferated across social media, falsely linking COVID-19 vaccines to widesprea …
The COVID-19 pandemic has exposed a parallel crisis: an infodemic of unprecedented scale and impact. ...Within this hostile in …
COVID-19 treatment of hospital patients worldwide at the onset of the pandemic in 2020: a systematic review.
Bosquet A, Affo C, Happe F, Helfer H, Versini E, Mahé I. Bosquet A, et al. BMC Infect Dis. 2025 Dec 17;26(1):107. doi: 10.1186/s12879-025-12368-2. BMC Infect Dis. 2025. PMID: 41408194 Free PMC article.
In early 2020, no drug had proven efficacy to treat COVID-19 in-patients. This work aimed to describe COVID-19 treatment for in-patients worldwide until June, 2020. ...Our study is not an exhaustive review of the literature on COVID-19 tr …
In early 2020, no drug had proven efficacy to treat COVID-19 in-patients. This work aimed to describe COVID-19 t …
Approval delays in multi-country COVID-19 trials: the case of COPCOV and the risk of therapeutic inertia.
Winters J, Schilling WH. Winters J, et al. Trials. 2025 Dec 16;27(1):58. doi: 10.1186/s13063-025-09300-z. Trials. 2025. PMID: 41402852 Free PMC article.
BACKGROUND: Many multi-country COVID-19 clinical trials, including those for widely available repurposed drugs with strong safety profiles, were conceptualised quickly but were unable to influence clinical treatment guidelines. The Chloroquine/Hydroxychloroquine
BACKGROUND: Many multi-country COVID-19 clinical trials, including those for widely available repurposed drugs with strong saf …
4,070 results